TipRanks
Go Ultimate75% OFF

Samuel Herschkowitz Insider Profile

4 Followers

Samuel Herschkowitz, former Director at Acerus Pharmaceuticals, holds 2.00K shares in Acerus Pharmaceuticals (Ticker: ASPCQ), holds 2.08M shares in Prospect Park Capital (Ticker: TSE:PPK). Most recently, Samuel Herschkowitz Bought ― shares of Acerus Pharmaceuticals on May 13, 2022 for an estimated value of $7.59K.

Samuel Herschkowitz's Trading History

ASPCQ
Acerus Pharmaceuticals
May 13, 2022―Informative Buy7.59K$438.00
PPK
Prospect Park Capital
Feb 14, 2017―Informative Buy―C$20.84K

You May Also Like

Samuel Herschkowitz insider profile FAQ

What is the percentage of profitable transactions made by Samuel Herschkowitz?
The percentage of profitable transactions made by Samuel Herschkowitz is 25%.
What is the average return per transaction made by Samuel Herschkowitz?
The average return per transaction made by Samuel Herschkowitz is -6.10%.
What stocks does Samuel Herschkowitz hold?
Samuel Herschkowitz holds: ASPCQ, TSE:PPK stocks.
What was Samuel Herschkowitz’s latest transaction?
Samuel Herschkowitz’s latest transaction was an Informative Buy of $7.59K.
What was Samuel Herschkowitz's most profitable transaction?
Samuel Herschkowitz’s most profitable transaction was an Informative Buy of TSE:PPK stock on February 14, 2017. The return on the trade was 121.20%.
What is Samuel Herschkowitz's role in Acerus Pharmaceuticals?
Samuel Herschkowitz's role in Acerus Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.